Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

Tumor-specific Cytotoxic Activity of 1,2,3,4-Tetrahydroisoquinoline Derivatives against Human Oral Squamous Cell Carcinoma Cell Lines

HAJIME HATANO, FUMIHIRO TAKEKAWA, KEN HASHIMOTO, MARIKO ISHIHARA, MASAMI KAWASE, CHU QING, WANG QIN-TAO and HIROSHI SAKAGAMI
Anticancer Research August 2009, 29 (8) 3079-3086;
HAJIME HATANO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
FUMIHIRO TAKEKAWA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KEN HASHIMOTO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MARIKO ISHIHARA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MASAMI KAWASE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHU QING
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
WANG QIN-TAO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HIROSHI SAKAGAMI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: sakagami{at}dent.meikai.ac.jp
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 29 no. 8 3079-3086
PMID 
19661319

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received April 6, 2009
  • Revision received June 2, 2009
  • Accepted June 15, 2009
  • Published online August 6, 2009.

Copyright & Usage 
Copyright© 2009 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. HAJIME HATANO1,
  2. FUMIHIRO TAKEKAWA1,
  3. KEN HASHIMOTO1,
  4. MARIKO ISHIHARA2,
  5. MASAMI KAWASE3,
  6. CHU QING1,4,
  7. WANG QIN-TAO4 and
  8. HIROSHI SAKAGAMI1
  1. 1Division of Pharmacology, Meikai University School of Dentistry, Sakado, Saitama 350-0283
  2. 2Division of Basic Chemistry, Meikai University School of Dentistry, Sakado, Saitama 350-0283
  3. 3Faculty of Pharmaceutical Sciences, Matsuyama University, Matsuyama, Ehime 790-8578, Japan
  4. 4Department of Periodontology and Oral Medicine, School of Stomatology, The Fourth Military Medical University, Xi'an, Shaanxi, P.R. China 710032
  1. Correspondence to: Hiroshi Sakagami, Division of Pharmacology, Department of Diagnostic and Therapeutic Sciences, Meikai University School of Dentistry, Sakado, Saitama 350-0283, Japan. Tel: +81 492792758, Fax: +81 492855171, e-mail: sakagami{at}dent.meikai.ac.jp
View Full Text

Statistics from Altmetric.com

Cited By...

  • 13 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 29, Issue 8
August 2009
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Tumor-specific Cytotoxic Activity of 1,2,3,4-Tetrahydroisoquinoline Derivatives against Human Oral Squamous Cell Carcinoma Cell Lines
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
3 + 16 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Tumor-specific Cytotoxic Activity of 1,2,3,4-Tetrahydroisoquinoline Derivatives against Human Oral Squamous Cell Carcinoma Cell Lines
HAJIME HATANO, FUMIHIRO TAKEKAWA, KEN HASHIMOTO, MARIKO ISHIHARA, MASAMI KAWASE, CHU QING, WANG QIN-TAO, HIROSHI SAKAGAMI
Anticancer Research Aug 2009, 29 (8) 3079-3086;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Tumor-specific Cytotoxic Activity of 1,2,3,4-Tetrahydroisoquinoline Derivatives against Human Oral Squamous Cell Carcinoma Cell Lines
HAJIME HATANO, FUMIHIRO TAKEKAWA, KEN HASHIMOTO, MARIKO ISHIHARA, MASAMI KAWASE, CHU QING, WANG QIN-TAO, HIROSHI SAKAGAMI
Anticancer Research Aug 2009, 29 (8) 3079-3086;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgements
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Quantitative Structure-Activity Relationship (QSAR) Analysis of Tumor-specificity of 1,2,3,4-Tetrahydroisoquinoline Derivatives
  • Estimation of Relationship Between Descriptors and Cytotoxicity of Newly Synthesized 1,2,3,4-Tetrahydroisoquinoline Derivatives
  • Google Scholar

More in this TOC Section

  • 6-O-Carboxypropyl-α-Tocotrienol Enhances the Anticancer Effects of Bortezomib Without Suppressing NRF1 and NRF3 in Colorectal Cancer Cells
  • Imbalance Between CD44 and STAT3 Enhances Spheroid Viability and Impairs Pembrolizumab Response in Urothelial Cancer
  • Imipramine Targets Apoptosis, Metastasis, and EGFR/SRC-mediated EMT in Oral Cancer Cells
Show more Experimental Studies
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire